• Skip to content
  • Skip to footer

Oklahoma Medical Research Foundation (OMRF)

Discoveries that make a difference.

  • About
    • Disease Research
    • History
    • Leadership
    • Education & Outreach
    • Effectiveness & Results
    • Events
    • Jobs
    • OMRF at a Glance
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • OMRF in the Media
    • OMRF News
    • OMRF Publications
    • OMRF Videos
  • Patients
    • Lupus (SLE)
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Syndrome
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Donor Events
    • Tax Credit
    • Gift Planning
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for glioblastoma

glioblastoma

OMRF discovers compound that could fight deadly cancer

January 21, 2019

Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.

Filed Under: News Tagged With: biomedical, brain, brain cancer, cancer, compound, cure, developed, drug, eltd1, glioblastoma, john mccain, medicine, news, newsok, nonprofit, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, pharma, Rheal, rheal towner, scientist-news, ted kennedy, Towner, treat, treatment

Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?

September 11, 2018

As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.

Filed Under: News, Technology Ventures News Tagged With: aggressive, battiste, brain, brain cancer, cancer, deadly, death, develop, disease, drug, glioblastoma, john mccain, life expectancy, live, longer, mike schuster, MRI, newsok, Norman, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OKN-007, OMRF, OUHSC, patients, Rheal, scientist-news, Stephenson Cancer Center, Towner, tumor

Biotech company acquires OMRF brain cancer drug

February 15, 2016

Agreement will expand clinical trials of glioblastoma drug

Filed Under: News Tagged With: brain cancer, brain tumor, cancer, clinical trial, glioblastoma, glioma, Gtree, GtreeBNT, investigational drug, Manu Nair, Oblato, OKN-007, pharmaceuticals, Rheal, scientist-news, Towner

New OMRF vice president focuses on bringing discoveries to the world

June 18, 2014

Technology Ventures works to pair scientists with industry partners.

Filed Under: Development News, Featured News, News Tagged With: biomedical, glioblastoma, industry, license, Manu Nair, Mayo Clinic, partner, technology ventures

Biomarkers help doctors decide how to treat brain cancers

September 10, 2013

OMRF’s biomarker discoveries could bring new therapies for beating gliomas.

Filed Under: Diseases, Featured News, News Tagged With: angiogenesis, antibody therapy, brain cancer, brain tumor, GAMMA, glioblastoma, glioma, Jonathan, jonathan wren, MRI, Randy Jensen, Rheal, rheal towner, scientist-news, Towner, Wren

OMRF brain cancer drug enters clinical trials at OU cancer center

August 7, 2013

OMRF, Stephenson Cancer Center begin tests of experimental compound

Filed Under: Diseases, News, Research News Tagged With: brain cancer, cancer, cancer center, Charles and Peggy Stephenson Cancer Center, clinical trials, drug study, drug trial, experimental treatment, glioblastoma, glioma, ou, Rheal, rheal towner, scientist-news, Stephenson Cancer Center, Towner, university of oklahoma

  • Page 1
  • Page 2
  • Page 3
  • Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Top Workplaces logo

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Charity navigator
United Way Give Smart OKC
Facebook Twitter YouTube Instagram Mail Linkedin
Administrator Log In